Viking Therapeutics
VKTX
VKTX
144 hedge funds and large institutions have $280M invested in Viking Therapeutics in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 156 → 144 (-12)
25% less capital invested
Capital invested by funds: $374M → $280M (-$94.2M)
44% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 25
Holders
144
Holding in Top 10
1
Calls
$17.3M
Puts
$7.82M
Top Buyers
| 1 | +$8.81M | |
| 2 | +$1.72M | |
| 3 | +$1.54M | |
| 4 |
Millennium Management
New York
|
+$1.16M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$1.05M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$4.02M | |
| 3 | -$3.95M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.86M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.32M |